The compound induces significant downstream c-MYC suppression and robust apoptosis induction in Burkitt’s lymphoma (BL) cells compared to the known BRD4 inhibitors, JQ-1 and OTX015. The gene discussed is BRD4; the disease is Burkitt lymphoma.